Join Dr. Jose Joglar, Chair of the 2023 U.S. AFib Guidelines, and Professor Gregory Lip, Chair of the ESC Council on Stroke, as they dive into the latest U.S. and European atrial fibrillation guidelines. From risk scores to rhythm control, they explore common ground, key differences, and the global shift toward holistic, patient-centered care. (Hint: coffee lovers with AFib, rejoice!)

Whether you’re a clinician navigating daily treatment decisions or a curious learner keeping up with cardiology guidelines, this is a must-listen conversation that reveals how far we’ve come in managing AFib and where we’re headed next. 

Topics covered:

• Point-of-care pathways 

• Anticoagulation and evolving risk scores

• Early rhythm control strategies

• Addressing AFib as a cardiometabolic disease

• Long-term impacts and future research priorities

Tune in now and subscribe to stay updated in expert insights in thrombosis and cardiovascular medicine!

For more resources, check out:

ESC Guidelines: Clinician Perspective: https://www.thieme-connect.com/products/ejournals/abstract/10.1055/a-2434-9244
2024 ESC Guidelines: https://academic.oup.com/eurheartj/article/45/36/3314/7738779?login=false
2023 U.S. Guidelines: https://www.ahajournals.org/doi/10.1161/CIR.0000000000001193

00:00 Introduction
01:57 Philosophies Behind AFib Guidelines
08:11 Lifestyle and Prevention in AFib
08:58 Evidence for Holistic Care: mAFA & MIRACLE Trials
12:34 Stroke Risk Scores and Future Research Needs
17:29 Rhythm vs Rate Control: Evolving Practice
20:56 Ablation, Drug Therapy, and Shared Decision-Making
22:12 The Caffeine Myth
24:31 Key Takeaways